NEWS
(1) Ph1/2 trial ongoing in US: NCT05068024.
(2) Ph1/2 trial ongoing in China: CTR20211750.
(1) Ph1/2 trial ongoing in US: NCT05068024.
(2) Ph1/2 trial ongoing in China: CTR20211750.